The TEVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TEVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The TEVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View TEVA Detailed Price Forecast - CNN Money||View TEVA Detailed Summary - Google Finance|
|View TEVA Detailed Summary - Yahoo! Finance||View TEVA Stock Research & Analysis - Zacks.com|
|View TEVA Trends & Analysis - Trade-Ideas||View TEVA Major Holders - Barrons|
|View TEVA Call Transcripts - NASDAQ||View TEVA Breaking News & Analysis - Seeking Alpha|
|View TEVA Annual Report - CompanySpotlight.com||View TEVA OTC Short Report - OTCShortReport.com|
|View TEVA Fundamentals - TradeKing||View TEVA SEC Filings - Bar Chart|
|View Historical Prices for TEVA - The WSJ||View Performance/Total Return for TEVA - Morningstar|
|View the Analyst Estimates for TEVA - MarketWatch||View the Earnings History for TEVA - CNBC|
|View the TEVA Earnings - StockMarketWatch||View TEVA Buy or Sell Recommendations - MacroAxis|
|View the TEVA Bullish Patterns - American Bulls||View TEVA Short Pain Metrics - ShortPainBot.com|
|View TEVA Stock Mentions - StockTwits||View TEVA Stock Mentions - PennyStockTweets|
|View TEVA Stock Mentions - Twitter||View TEVA Investment Forum News - Investor Hub|
|View TEVA Stock Mentions - Yahoo! Message Board||View TEVA Stock Mentions - Seeking Alpha|
|View Insider Transactions for TEVA - SECform4.com||View Insider Transactions for TEVA - Insider Cow|
|View TEVA Major Holdings Summary - CNBC||View Insider Disclosure for TEVA - OTC Markets|
|View Insider Transactions for TEVA - Yahoo! Finance||View Institutional Holdings for TEVA - NASDAQ|
|View TEVA Stock Insight & Charts - FinViz.com||View TEVA Investment Charts - StockCharts.com|
|View TEVA Stock Overview & Charts - BarChart||View TEVA User Generated Charts - Trading View|
Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial
Posted on Monday March 25, 2019
The Oklahoma Supreme Court's decision was a win for the state's attorney general, whose case is set to be the first to face trial of roughly 2,000 lawsuits nationally seeking to hold opioid manufacturers responsible for contributing to the epidemic. Oklahoma Attorney General Mike Hunter's 2017 lawsuit accuses Purdue, Johnson & Johnson & Teva Pharmaceutical Industries Ltd of engaging in deceptive marketing that downplayed the risks of addiction associated with opioid pain drugs while overstating their benefits. The trial delay bid came as Purdue, owned by members of the wealthy Sackler family, was exploring filing for Chapter 11 bankruptcy protection to address potential liabilities stemming from the lawsuits, people familiar with the matter have told Reuters.
Why Wall Street Has Mixed Opinions on Teva Pharmaceutical
Posted on Monday March 25, 2019
How Generic Pharmaceutical Stocks Are Positioned this MonthAnalysts’ recommendations and target prices Wall Street analysts expect an upside potential of 24.43% for Teva Pharmaceutical (TEVA), based on the company’s closing price on March 22. In
Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States
Posted on Friday March 22, 2019
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older.
Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision
Posted on Wednesday March 20, 2019
The FDA will provide its decision on Jazz's (JAZZ) candidate, solriamfetol, for excessive daytime sleepiness with narcolepsy on Wednesday.